A Phase 2/3 multicenter randomized study of Rituximabgemcitabine-Dexamethasone-Platinum (R-GDP) with or without Selinexor in Patients with relapsed/refractory Diffuse Large B-Cell Lymphoma (RR DLBCL)

Project: Clinical studies › Clinical Study (Industry project)

Project Details

StatusFinished
Effective start/end date09.10.2020 → 30.12.2022

Fields of science

  • 302007 Ophthalmology